Global Ophthalmology Therapeutics Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	170 Pages	TechNavio	December, 2022	INF17613480

Best Price Guarantee
Price	from $2,500
Length	170 Pages
Publisher	TechNavio
Published Date	December, 2022
SKU	INF17613480

Global Ophthalmology Therapeutics Market 2023-2027

Technavio has been monitoring the ophthalmology therapeutics market and is forecast to grow by $15.72 bn during 2022-2027, accelerating at a CAGR of 6.25% during the forecast period. Our report on the ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in the prevalence of eye diseases, approval of novel therapeutics and strong drug pipeline, and strong uptake of anti-VEGF inhibitors.

Technavio's ophthalmology therapeutics market is segmented as below:

By Product

Retinal disorder
Glaucoma
Dry eye disease
Eye infections and inflammation
Other therapeutics

By Type

Prescription drugs
OTC drugs

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of novel drug delivery systems as one of the prime reasons driving the ophthalmology therapeutics market growth during the next few years. Also, increase in strategic alliances and increasing research on gene therapy products will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the ophthalmology therapeutics market covers the following areas:

Ophthalmology therapeutics market sizing
Ophthalmology therapeutics market forecast
Ophthalmology therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ophthalmology therapeutics market vendors that include AbbVie Inc., Adrif Vision, Aldeyra Therapeutics Inc., Bausch Health Co Inc., Bayer AG, Eyeris Vision Care Pvt. Ltd., F. Hoffmann La Roche Ltd., Grevis Pharmaceuticals Pvt. Ltd., Novartis AG, Ocular Therapeutix Inc., Otsuka Pharmaceutical Co. Ltd., Oxurion NV, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Swissvision, Teva Pharmaceutical Industries Ltd., Vee Remedies, and Visufarma. Also, the ophthalmology therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Product
  - Table Executive Summary – Chart on Market Segmentation by Type
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Global - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Historic Market Size
- Global ophthalmology therapeutics market 2017 - 2021
  - Table Historic Market Size – Data table on global ophthalmology therapeutics market 2017 - 2021 ($ billion)
- Product Segment Analysis 2017 - 2021
  - Table Historic Market Size – Product Segment 2017 - 2021 ($ billion)
- Type Segment Analysis 2017 - 2021
  - Table Historic Market Size – Type Segment 2017 - 2021 ($ billion)
- Geography Segment Analysis 2017 - 2021
  - Table Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
- Country Segment Analysis 2017 - 2021
  - Table Historic Market Size – Country Segment 2017 - 2021 ($ billion)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Product
- Market segments
  - Table Chart on Product - Market share 2022-2027 (%)
  - Table Data Table on Product - Market share 2022-2027 (%)
- Comparison by Product
  - Table Chart on Comparison by Product
  - Table Data Table on Comparison by Product
- Retinal disorder therapeutics - Market size and forecast 2022-2027
  - Table Chart on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
- Glaucoma therapeutics - Market size and forecast 2022- 2027
  - Table Chart on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
- Dry eye disease therapeutics - Market size and forecast 2022-2027
  - Table Chart on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
- Eye infections and inflammation therapeutics – Market size and forecast 2022-2027
  - Table Chart on Eye infections and inflammation therapeutics - Market size and forecast 2022- 2027 ($ billion)
  - Table Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2022- 2027 (%)
- Other therapeutics - Market size and forecast 2022-2027
  - Table Chart on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
- Market opportunity by Product
  - Table Market opportunity by Product ($ billion)
Market Segmentation by Type
- Market segments
  - Table Chart on Type - Market share 2022-2027 (%)
  - Table Data Table on Type - Market share 2022-2027 (%)
- Comparison by Type
  - Table Chart on Comparison by Type
  - Table Data Table on Comparison by Type
- Prescription drugs - Market size and forecast 2022-2027
  - Table Chart on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
- OTC drugs - Market size and forecast 2022-2027
  - Table Chart on OTC drugs - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on OTC drugs - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
  - Table Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
- Market opportunity by Type
  - Table Market opportunity by Type ($ billion)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2022-2027 (%)
  - Table Data Table on Market share by geography 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2022-2027
  - Table Chart on North America - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on North America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on North America - Year-over-year growth 2022-2027 (%)
- Europe - Market size and forecast 2022-2027
  - Table Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Europe - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Asia - Market size and forecast 2022-2027
  - Table Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Asia - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Rest of World (ROW) - Market size and forecast 2022- 2027
  - Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- US - Market size and forecast 2022-2027
  - Table Chart on US - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on US - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on US - Year-over-year growth 2022-2027 (%)
  - Table Data Table on US - Year-over-year growth 2022-2027 (%)
- Germany - Market size and forecast 2022-2027
  - Table Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Germany - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
- UK - Market size and forecast 2022-2027
  - Table Chart on UK - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on UK - Year-over-year growth 2022-2027 (%)
  - Table Data Table on UK - Year-over-year growth 2022-2027 (%)
- France - Market size and forecast 2022-2027
  - Table Chart on France - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on France - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on France - Year-over-year growth 2022-2027 (%)
  - Table Data Table on France - Year-over-year growth 2022-2027 (%)
- Japan - Market size and forecast 2022-2027
  - Table Chart on Japan - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Japan - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Japan - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ billion)
Drivers, Challenges, and Trends
- Market drivers
  - Increase in prevalence of eye diseases
  - Approval of novel therapeutics and strong drug pipeline
  - Strong uptake of anti-VEGF inhibitors
- Market challenges
  - Expiry of patents on major therapeutics
  - High costs of treatment
  - Side effects of current ophthalmology therapeutics
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - Development of novel drug delivery systems
  - Increase in strategic alliances
  - Increasing research on gene therapy products
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key news
  - Table AbbVie Inc. - Key offerings
- Aldeyra Therapeutics Inc.
  - Table Aldeyra Therapeutics Inc. - Overview
  - Table Aldeyra Therapeutics Inc. - Product / Service
  - Table Aldeyra Therapeutics Inc. - Key offerings
- Bausch Health Co Inc.
  - Table Bausch Health Co Inc. - Overview
  - Table Bausch Health Co Inc. - Business segments
  - Table Bausch Health Co Inc. - Key news
  - Table Bausch Health Co Inc. - Key offerings
  - Table Bausch Health Co Inc. - Segment focus
- Bayer AG
  - Table Bayer AG - Overview
  - Table Bayer AG - Business segments
  - Table Bayer AG - Key news
  - Table Bayer AG - Key offerings
  - Table Bayer AG - Segment focus
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Ocular Therapeutix Inc.
  - Table Ocular Therapeutix Inc. - Overview
  - Table Ocular Therapeutix Inc. - Product / Service
  - Table Ocular Therapeutix Inc. - Key offerings
- Otsuka Pharmaceutical Co. Ltd.
  - Table Otsuka Pharmaceutical Co. Ltd. - Overview
  - Table Otsuka Pharmaceutical Co. Ltd. - Product / Service
  - Table Otsuka Pharmaceutical Co. Ltd. - Key offerings
- Oxurion NV
  - Table Oxurion NV - Overview
  - Table Oxurion NV - Product / Service
  - Table Oxurion NV - Key offerings
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Regeneron Pharmaceuticals Inc.
  - Table Regeneron Pharmaceuticals Inc. - Overview
  - Table Regeneron Pharmaceuticals Inc. - Product / Service
  - Table Regeneron Pharmaceuticals Inc. - Key offerings
- Santen Pharmaceutical Co. Ltd.
  - Table Santen Pharmaceutical Co. Ltd. - Overview
  - Table Santen Pharmaceutical Co. Ltd. - Product / Service
  - Table Santen Pharmaceutical Co. Ltd. - Key offerings
- Sun Pharmaceutical Industries Ltd.
  - Table Sun Pharmaceutical Industries Ltd. - Overview
  - Table Sun Pharmaceutical Industries Ltd. - Product / Service
  - Table Sun Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd.
  - Table Teva Pharmaceutical Industries Ltd. - Overview
  - Table Teva Pharmaceutical Industries Ltd. - Business segments
  - Table Teva Pharmaceutical Industries Ltd. - Key news
  - Table Teva Pharmaceutical Industries Ltd. - Key offerings
  - Table Teva Pharmaceutical Industries Ltd. - Segment focus
- Visufarma
  - Table Visufarma - Overview
  - Table Visufarma - Product / Service
  - Table Visufarma - Key offerings
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations